On April 16, 2026, Vir Biotechnology, Inc. announced the closing of its global collaboration and licensing agreement with Astellas for VIR-5500 in metastatic prostate cancer, securing a US$240,000,000 ...
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned ...
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...
The biotechnical research at the HudsonAlpha Institute for Biotechnology is once again in the national spotlight. The ...
BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development platform ...
Central Ohio is a growing U.S. biotech hub because of decades of efforts, the head of a national trade group says.
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...
Apple — Shares were up 2%. For the fiscal second quarter , Apple's earnings came in at $2.01 per share, while revenue landed ...
The National Universities Commission (NUC) has granted full accreditation to the Biotechnology programme at McPherson University, Lagos-Ibadan Expressway, Ogun State, marking a significant milestone ...
Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results